Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one-year randomized controlled trial comparing systematic versus on-demand treatment
✍ Scribed by Maxime Breban; Philippe Ravaud; Pascal Claudepierre; Gabriel Baron; Yves-Dominique Henry; Christophe Hudry; Liana Euller-Ziegler; Thao Pham; Elisabeth Solau-Gervais; Isabelle Chary-Valckenaere; Christian Marcelli; Aleth Perdriger; Xavier Le Loët; Daniel Wendling; Bruno Fautrel; Bernard Fournié; Bernard Combe; Philippe Gaudin; Sandrine Jousse; Xavier Mariette; Alain Baleydier; Gérard Trape; Maxime Dougados; French Ankylosing Spondylitis Infliximab Network
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 162 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To determine whether the effects of anti–tumor necrosis factor α (TNFα) in reducing the signs and symptoms of ankylosing spondylitis (AS) coincide with a reduction in spinal inflammation as detected by magnetic resonance imaging (MRI). ## Methods Pre‐ and postgadolinium